Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Steve Barton: Silver, Gold at New Highs, Here’s... January 23, 2026 High Grade Cu-Au at Surface Delivers New Targets... July 9, 2025 Tech Weekly: Stocks See Minor Reprieve Before Ending... February 28, 2026 Québec Communities Vote “No” to La Loutre Graphite... September 6, 2025 Quimbaya Gold Announces Termination of LOI with Denarius... August 2, 2025 Horn Island Project Update November 5, 2025 Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin... April 26, 2025 EVs Now Emit 73 percent Less Than Gasoline... July 11, 2025 White Cliff Minerals Limited (ASX: WCN) – Trading... May 5, 2025 Lithium Universe LtdSettlement of Tranche 1 Share Placement June 26, 2025